Jérôme Tiollier

MECHANISMS INVOLVED IN ANTITHYMOCYTE GLOBULIN IMMUNOSUPPRESSIVE ACTIVITY IN A NONHUMAN PRIMATE MODEL 1

Xavier Préville, Monique Flacher, BRIGITTE LEMAUFF et al. · Transplantation · 2001 · 279 citations

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

Jaafar Bennouna, Emmanuelle Bompas, Eve Marie Neidhardt et al. · Cancer Immunology Immunotherapy · 2008 · 237 citations · Full text

γ9δ2 T, Cancer Immunosurveillance, Innacell γδ™ +12

A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Don M. Benson, Craig C. Hofmeister, Attaya Suvannasankha et al. · Blood · 2012 · 236 citations · Full text

In Vivo Immunomanipulation of Vγ9Vδ2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model

Hélène Sicard, Sophie Ingoure, Béatrice Luciani et al. · The Journal of Immunology · 2005 · 185 citations · Full text

Primate Blood, Adaptive Immune System, Immunology +19

In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute

Estelle Tinois, Jérôme Tiollier, M Gaucherand et al. · Experimental Cell Research · 1991 · 167 citations

Regenerative Medicine, Tissue Engineering, Skin Development +15